摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-fluorobenzyl)-2-(benzyloxy)-1,3-dioxo-7-phenylacetamido-1,2,3,4-tetrahydroisoquinoline-4-carboxamide | 1383786-43-3

中文名称
——
中文别名
——
英文名称
N-(4-fluorobenzyl)-2-(benzyloxy)-1,3-dioxo-7-phenylacetamido-1,2,3,4-tetrahydroisoquinoline-4-carboxamide
英文别名
N-[(4-fluorophenyl)methyl]-1,3-dioxo-7-[(2-phenylacetyl)amino]-2-phenylmethoxy-4H-isoquinoline-4-carboxamide
N-(4-fluorobenzyl)-2-(benzyloxy)-1,3-dioxo-7-phenylacetamido-1,2,3,4-tetrahydroisoquinoline-4-carboxamide化学式
CAS
1383786-43-3
化学式
C32H26FN3O5
mdl
——
分子量
551.574
InChiKey
HBEXERRFTYFAIX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    225-229 °C
  • 密度:
    1.38±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    41
  • 可旋转键数:
    9
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    105
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    N-(4-fluorobenzyl)-2-(benzyloxy)-1,3-dioxo-7-phenylacetamido-1,2,3,4-tetrahydroisoquinoline-4-carboxamide 在 5%-palladium/activated carbon 、 氢气 作用下, 以 甲醇乙酸乙酯 为溶剂, 以83%的产率得到N-(4-fluorobenzyl)-2-hydroxy-1,3-dioxo-7-phenylacetamido-1,2,3,4-tetrahydroisoquinoline-4-carboxamide
    参考文献:
    名称:
    Investigation of a Novel Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Human Immunodeficiency Virus Type 1 Integrase Inhibitors
    摘要:
    We report herein further insight into the biological activities displayed by a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs). Substitution of the N-hydroxyimide two-metal binding pharmacophore at position 4 by carboxamido side chains was previously shown by us to be fruitful for this scaffold, since strong human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitors in the low nanomolar range associated with low micromolar anti-HIV activities were obtained. We investigated the influence of substitution at position 7 on biological activity. Introduction of electron-withdrawing functional groups such as the nitro moiety at position 7 led to a noticeable improvement of antiviral activity, down to low nanomolar anti-HIV potencies, with advantageous therapeutic indexes going close to those of the clinically used raltegravir and retained potencies against a panel of IN mutants.
    DOI:
    10.1021/jm500109z
  • 作为产物:
    描述:
    参考文献:
    名称:
    Investigation of a Novel Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Human Immunodeficiency Virus Type 1 Integrase Inhibitors
    摘要:
    We report herein further insight into the biological activities displayed by a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs). Substitution of the N-hydroxyimide two-metal binding pharmacophore at position 4 by carboxamido side chains was previously shown by us to be fruitful for this scaffold, since strong human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitors in the low nanomolar range associated with low micromolar anti-HIV activities were obtained. We investigated the influence of substitution at position 7 on biological activity. Introduction of electron-withdrawing functional groups such as the nitro moiety at position 7 led to a noticeable improvement of antiviral activity, down to low nanomolar anti-HIV potencies, with advantageous therapeutic indexes going close to those of the clinically used raltegravir and retained potencies against a panel of IN mutants.
    DOI:
    10.1021/jm500109z
点击查看最新优质反应信息

文献信息

  • [EN] 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS<br/>[FR] 2 -HYDROXYISOQUINOLINE- 1, 3 ( 2H, 4H) - DIONES ET COMPOSÉS ASSOCIÉS SERVANT D'INHIBITEURS DE LA RÉPLICATION DU VIH
    申请人:UNIV LEUVEN KATH
    公开号:WO2012085003A1
    公开(公告)日:2012-06-28
    The present invention relates to compounds and compositions acting as inhibitors of HIV integrase. The compound of the invention is of Formula (I), or a tautomer (I') thereof, or a pharmaceutically acceptable salt, or solvate of said compound or tautomer thereof, wherein R1, R2, R3, R4, R5 and R6 have defined meanings.
    本发明涉及作为HIV整合酶抑制剂的化合物和组合物。该发明的化合物为式(I)的化合物,或其互变异构体(I'),或所述化合物或其互变异构体的药用可接受盐或溶剂,其中R1、R2、R3、R4、R5和R6具有定义的含义。
查看更多

同类化合物

(6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 顺式-4-(2,2-二甲氧基乙基)-3-邻苯二甲酰-2-氮杂环丁酮 顺式-3-氨基-1-(2,4-二甲氧基苄基)-4-甲氧羰基-2-氮杂环丁酮 顺式-1-(对甲苯基)-3-苄氧基-4-(对茴香基)-氮杂环丁烷-2-酮 顺式-1,4-二苯基-3-(甲基苯基氨基)-2-氮杂环丁酮 青霉酰聚赖氨酸 青霉素钾 青霉素钠 青霉素酶液体 青霉素杂质F氢化物 青霉素杂质C 青霉素亚砜酯(GESO) 青霉素V二苄乙二胺 青霉素G衍生物 青霉素G甲酯 青霉素G甲酯 青霉素G-D7 青霉素 V 钠 阿那白滞素 阿莫西林钠 阿莫西林三水合物 阿莫西林 阿立必利D5 阿度西林 铜(2+)酞菁-29,30-二负离子-2-(二甲氨基)乙醇(1:1:1) 钾(2S,5R,6R)-6-[[2-[(E)-3-氯丁-2-烯基]巯基乙酰基]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸酯 钠6-[[3-(2-氯-6-氟苯基)-5-甲基1,2-恶唑-4-羰基]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸盐水合物 钠(6S,7R)-3-(羟基甲基)-7-甲氧基-8-氧代-7-[(2-噻吩基乙酰基)氨基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯 钠(6R,7R)-7-[[(2Z)-2-(2-氨基-1,3-噻唑-4-基)-2-甲氧基亚氨基乙酰基]氨基]-8-氧代-3-[(2S)-四氢呋喃-2-基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯 钠(2S,5R,6R)-6-[(2-叠氮基-2-苯基乙酰基)氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸盐 酞氨西林 赖氨酸氯尼辛 萘夫西林钠 萘夫西林钠 萘夫西林杂质 苯磺酸,2-[(2-羟基-1-萘基)偶氮]-5-甲基-,盐(2:1)钡 苯甘孢霉素亚砜 苯氧乙基青霉素钾 苯并[b]噻吩-3-羧酸,2-[3-氯-2-(4-硝基苯基)-4-羰基-1-吖丁啶基]-4,5,6,7-四氢-,乙基酯 苯唑西林钠 苯唑西林杂质1 舒巴坦杂质19 舒他西林 脱乙酰基戊二酰 7-氨基头孢烷酸 脱乙酰基头孢噻肟 肟莫南 羰苄西林苯酯钠 美罗培南钠盐 美罗培南 美洛培南